+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Circassia Pharmaceuticals - logo

Circassia is a pharmaceutical company that innovates products for respiratory diseases. Circassia was established in 2006 in Morrisville, U.S. In March 2014 they completed an initial public offering on the London Stock Exchange.The product Tudorza is marketed by Circassia which is a product used to treat COPD chronic obstructive pulmonary disease.Circassia collaborates with Astra Zeneca which helps them promote Tudorza and it gives them rights to Duaklir® which has increased their sales majorly. Also in 2015, they completed acquisitions with Aerocrine and Prosonix which helps them to commercialize their products and broaden their pipelines.

From
From
From
From
From
From
From
From
Microneedles for Trans / Intradermal Drug Delivery - Product Thumbnail Image

Microneedles for Trans / Intradermal Drug Delivery

  • Report
  • October 2014
  • 210 Pages
From
Global Peptide Vaccine Market & Pipeline Insight - Product Thumbnail Image

Global Peptide Vaccine Market & Pipeline Insight

  • Drug Pipelines
  • January 2015
  • 200 Pages
From
Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Conjunctivitis Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • December 2020
  • 461 pages
From
From
Grass Pollen Allergy Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Grass Pollen Allergy Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • August 2020
  • 125 pages
From
Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • July 2020
  • 216 pages
From
Conjunctivitis Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Conjunctivitis Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • June 2020
  • 433 pages
From
From
Cat Allergy Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Cat Allergy Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • December 2018
  • 50 pages
From
From
Type I Hypersensitivity Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Type I Hypersensitivity Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • September 2018
  • 565 pages
From
Loading Indicator
adroll